- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Next-generation PET/CT arrives
Siemens Medical Solutions will showcase a new biograph family of PET/CT scanners at the RSNA meeting. Features include a high-resolution PET option, image quality enhancement, a six-slice CT biograph companion to existing two- and 16-slice
Siemens Medical Solutions will showcase a new biograph family of PET/CT scanners at the RSNA meeting. Features include a high-resolution PET option, image quality enhancement, a six-slice CT biograph companion to existing two- and 16-slice configurations, and high-performance image processing on an enhanced version of the Siemens' Leonardo workstation. Most notable is the introduction of an advanced form of lutetium oxyorthosilicate, the detector material. This form of LSO, called HI-REZ, promises a 250% improvement in volumetric image resolution, according to the company. The improved workstation integrates more than 50 multimodality imaging applications, including CT applications addressing radiation therapy planning and lung analysis, in a single user interface.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
